Trial Information
Summary: Treatment of Hospital Acquired Pneumonia
Multinational trial of treatment for Hospital Acquired Pneumonia
with an emphasis on patients with infections due to
methicillin-resistant Staphylococcus aureus.
Several Study Inclusion Criteria Include:
- Pneumonia acquired after 48 hours of continuous stay in an
inpatient facility
Several Study Exclusion Criteria Include:
- Known or suspected pulmonary disease that would preclude
evaluation of therapeutic response
- Known or suspected Legionella Pneumophila
|
Contact:
Holy Cross Hospital Research Center
4875 N. Federal Hwy, Suite 700
Fort Lauderdale, FL 33308
Telephone: 954-229-8400
Fax: 954-229-8597
|
|

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: February 25, 2008 at 2:32:24 PM